skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Economic evaluation of nivolumab as a second‐line treatment for advanced renal cell carcinoma from US and Chinese perspectives

Cancer, 2017-07, Vol.123 (14), p.2634-2641 [Peer Reviewed Journal]

2017 American Cancer Society ;2017 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.30666 ;PMID: 28301684

Digital Resources/Online E-Resources

Citations Cited by

Searching Remote Databases, Please Wait